Helicobacter pylori and gastrointestinal tract adenocarcinomas (original) (raw)
Correa, P. Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol. Biomarkers Prev.5, 477–481 (1996). CASPubMed Google Scholar
Peterson, W. L. Helicobacter pylori and peptic ulcer disease. N. Engl. J. Med.324, 1043–1048 (1991). ArticleCASPubMed Google Scholar
Parsonnet, J. et al. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med.330, 1267–1271 (1994). ArticleCASPubMed Google Scholar
Karnes, W. E. Jr et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology101, 167–174 (1991). ArticlePubMed Google Scholar
Forman, D. et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br. Med. J.302, 1302–1305 (1991). ArticleCAS Google Scholar
Nomura, A. et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med.325, 1132–1136 (1991). ArticleCASPubMed Google Scholar
Parsonnet, J. et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med.325, 1127–1131 (1991).References6and7represent two of the original studies that established a positive relationship between pre-existingH. pyloriand risk of developing gastric adenocarcinoma. ArticleCASPubMed Google Scholar
Watanabe, Y. et al. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. Dig. Dis. Sci.42, 1383–1387 (1997). ArticleCASPubMed Google Scholar
Sipponen, P., Kosunen, T. U., Valle, J., Riihela, M. & Seppala, K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J. Clin. Pathol.45, 319–323 (1992). ArticleCASPubMedPubMed Central Google Scholar
Hansson, L. E. et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology105, 1098–1103 (1993). ArticleCASPubMed Google Scholar
Vicari, J. J. et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology115, 50–57 (1998).This study shows thatH. pylori cagA+ strains are reciprocally related to the prevalence of GERD and its complications, indicating that certainH. pyloristrains might confer a beneficial effect upon their hosts. ArticleCASPubMed Google Scholar
Chow, W. H. et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res.58, 588–590 (1998). CASPubMed Google Scholar
Everhart, J. E. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol. Clin. N. Am.29, 559–578 (2000). ArticleCAS Google Scholar
Ernst, P. B. & Gold, B. D. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu. Rev. Microbiol.54, 615–640 (2000). ArticleCASPubMed Google Scholar
Perez-Perez, G. I., Dworkin, B. M., Chodos, J. E. & Blaser, M. J. Campylobacter pylori antibodies in humans. Ann. Intern. Med.109, 11–17 (1988). ArticleCASPubMed Google Scholar
Tindberg, Y. et al. Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology121, 310–316 (2001). ArticleCASPubMed Google Scholar
Parsonnet, J., Shmuely, H. & Haggerty, T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. J. Am. Med. Assoc.282, 2240–2245 (1999). ArticleCAS Google Scholar
Sipponen, P. & Marshall, B. J. Gastritis and gastric cancer. Western countries. Gastroenterol. Clin. N. Am.29, 579–592 (2000). ArticleCAS Google Scholar
Maesawa, C. et al. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma–carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J. Pathol.176, 249–258 (1995). ArticleCASPubMed Google Scholar
Uchino, S. et al. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int. J. Cancer54, 759–764 (1993). ArticleCASPubMed Google Scholar
Hongyo, T. et al. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res.55, 2665–2672 (1995). CASPubMed Google Scholar
Blaser, M. J. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J. Infect. Dis.161, 626–633 (1990). ArticleCASPubMed Google Scholar
Parsonnet, J. The incidence of Helicobacter pylori infection. Aliment. Pharmacol. Ther.9, 45–51 (1995). PubMed Google Scholar
Howson, C. P., Hiyama, T. & Wynder, E. L. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol. Rev.8, 1–27 (1986). ArticleCASPubMed Google Scholar
Siman, J. H., Forsgren, A., Berglund, G. & Floren, C. H. Association between Helicobacter pylori and gastric carcinoma in the city of Malmo, Sweden. A prospective study. Scand. J. Gastroenterol.32, 1215–1221 (1997). ArticleCASPubMed Google Scholar
Hu, P. J., Mitchell, H. M., Li, Y. Y., Zhou, M. H. & Hazell, S. L. Association of Helicobacter pylori with gastric cancer and observations on the detection of this bacterium in gastric cancer cases. Am. J. Gastroenterol.89, 1806–1810 (1994). CASPubMed Google Scholar
Kikuchi, S. et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Cancer75, 2789–2793 (1995). ArticleCASPubMed Google Scholar
Kokkola, A. et al. Helicobacter pylori infection in young patients with gastric carcinoma. Scand. J. Gastroenterol.31, 643–647 (1996). ArticleCASPubMed Google Scholar
Barreto-Zuniga, R. et al. Significance of Helicobacter pylori infection as a risk factor in gastric cancer: serological and histological studies. J. Gastroenterol.32, 289–294 (1997). ArticleCASPubMed Google Scholar
Miehlke, S. et al. Histological diagnosis of Helicobacter pylori gastritis is predictive of a high risk of gastric carcinoma. Int. J. Cancer73, 837–839 (1997). ArticleCASPubMed Google Scholar
Gastric cancer and Helicobacter pylori: a combined analysis of 12 case-control studies nested within prospective cohorts. Gut49, 347–353 (2001).
Correa, P. et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J. Natl Cancer Inst.92, 1881–1888 (2000).One of the few large, randomized, controlled chemoprevention trials showing thatH. pylorieradication increased the regression rate of pre-malignant lesions within the gastric mucosa. ArticleCASPubMed Google Scholar
Uemura, N. et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol. Biomarkers Prev.6, 639–642 (1997). CASPubMed Google Scholar
Uemura, N. et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med.345, 784–789 (2001). ArticleCASPubMed Google Scholar
Hirayama, F., Takagi, S., Yokoyama, Y., Iwao, E. & Ikeda, Y. Establishment of gastric Helicobacter pylori infection in Mongolian gerbils. J. Gastroenterol.31 (Suppl. 9), 24–28 (1996). PubMed Google Scholar
Watanabe, T., Tada, M., Nagai, H., Sasaki, S. & Nakao, M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology115, 642–648 (1998).A seminal article reporting thatH. pyloricolonization alone, in the absence of administration of co-carcinogens, leads to the development of intestinal-type gastric adenocarcinoma in Mongolian gerbils. The sequence of histological lesions observed in this paper parallels the predominant histological pattern of intestinal-type gastric cancer found in humans, and so established this rodent system as a unique model of carcinogenesis induced byH. pylori. ArticleCASPubMed Google Scholar
Honda, S. et al. Development of _Helicobacter pylori_-induced gastric carcinoma in Mongolian gerbils. Cancer Res.58, 4255–4259 (1998). CASPubMed Google Scholar
Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum.61, 1–241 (1994).
Go, M. F., Kapur, V., Graham, D. Y. & Musser, J. M. Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J. Bacteriol.178, 3934–3938 (1996). ArticleCASPubMedPubMed Central Google Scholar
Israel, D. A. et al. Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc. Natl Acad. Sci. USA98, 14625–14630 (2001). ArticleCASPubMedPubMed Central Google Scholar
van Doorn, L. J. et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology115, 58–66 (1998). ArticleCASPubMed Google Scholar
Gerhard, M. et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc. Natl Acad. Sci. USA96, 12778–12783 (1999). ArticleCASPubMedPubMed Central Google Scholar
Tomb, J. F. et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature388, 539–547 (1997).The annotated description of the entire genome sequence from a singleH. pyloristrain. This study provided a framework for investigations intoH. pylori–host interactions and how these affect carcinogenesis. ArticleCASPubMed Google Scholar
Alm, R. A. et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature397, 176–180 (1999).The comparison of genome sequences from two unrelatedH. pyloristrains underscored the high degree of genetic diversity that exists within this species and identified numerous strain-specific loci that might have a role in pathogenesis. ArticlePubMedCAS Google Scholar
Odenbreit, S. et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science287, 1497–1500 (2000). ArticleCASPubMed Google Scholar
Stein, M., Rappuoli, R. & Covacci, A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after _cag_-driven host cell translocation. Proc. Natl Acad. Sci. USA97, 1263–1268 (2000). ArticleCASPubMedPubMed Central Google Scholar
Asahi, M. et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med.191, 593–602 (2000). ArticleCASPubMedPubMed Central Google Scholar
Segal, E. D., Cha, J., Lo, J., Falkow, S. & Tompkins, L. S. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl Acad. Sci. USA96, 14559–14564 (1999). ArticleCASPubMedPubMed Central Google Scholar
Cover, T. L., Dooley, C. P. & Blaser, M. J. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect. Immun.58, 603–610 (1990). ArticleCASPubMedPubMed Central Google Scholar
Crabtree, J. E. et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet338, 332–335 (1991). ArticleCASPubMed Google Scholar
Peek, R. M. Jr et al. Heightened inflammatory response and cytokine expression in vivo to cagA+Helicobacter pylori strains. Lab. Invest.73, 760–770 (1995). CASPubMed Google Scholar
Kuipers, E. J., Perez-Perez, G. I., Meuwissen, S. G. & Blaser, M. J. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J. Natl Cancer Inst.87, 1777–1780 (1995). ArticleCASPubMed Google Scholar
Blaser, M. J. et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res.55, 2111–2115 (1995). CASPubMed Google Scholar
Parsonnet, J., Friedman, G. D., Orentreich, N. & Vogelman, H. Risk for gastric cancer in people with CagA+ or CagA−Helicobacter pylori infection. Gut40, 297–301 (1997). ArticleCASPubMedPubMed Central Google Scholar
Sharma, S. A., Tummuru, M. K., Miller, G. G. & Blaser, M. J. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect. Immun.63, 1681–1687 (1995). ArticleCASPubMedPubMed Central Google Scholar
Tummuru, M. K., Sharma, S. A. & Blaser, M. J. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol.18, 867–876 (1995). ArticleCASPubMed Google Scholar
Glocker, E. et al. Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-κB activation. Infect. Immun.66, 2346–2348 (1998). ArticleCASPubMedPubMed Central Google Scholar
Sharma, S. A., Tummuru, M. K., Blaser, M. J. & Kerr, L. D. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-κB in gastric epithelial cells. J. Immunol.160, 2401–2407 (1998). CASPubMed Google Scholar
Keates, S. et al. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag_−_Helicobacter pylori. J. Immunol.163, 5552–5559 (1999). CASPubMed Google Scholar
Naumann, M. et al. Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J. Biol. Chem.274, 31655–31662 (1999). ArticleCASPubMed Google Scholar
Meyer-Ter-Vehn, T., Covacci, A., Kist, M. & Pahl, H. L. Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J. Biol. Chem.275, 16064–16072 (2000). ArticleCASPubMed Google Scholar
Yamaoka, Y., Kita, M., Kodama, T., Sawai, N. & Imanishi, J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology110, 1744–1752 (1996). ArticleCASPubMed Google Scholar
Ogura, K. et al. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J. Exp. Med.192, 1601–1610 (2000). ArticleCASPubMedPubMed Central Google Scholar
Israel, D. A. et al. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J. Clin. Invest.107, 611–620 (2001). ArticleCASPubMedPubMed Central Google Scholar
Rudi, J. et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in _Helicobacter pylori_-induced gastric epithelial apoptosis. J. Clin. Invest.102, 1506–1514 (1998). ArticleCASPubMedPubMed Central Google Scholar
Peek, R. M. Jr et al. Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res.59, 6124–6131 (1999). CASPubMed Google Scholar
Galmiche, A. et al. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J.19, 6361–6370 (2000). ArticleCASPubMedPubMed Central Google Scholar
Kuck, D. et al. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect. Immun.69, 5080–5087 (2001). ArticleCASPubMedPubMed Central Google Scholar
Leunk, R. D., Johnson, P. T., David, B. C., Kraft, W. G. & Morgan, D. R. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol.26, 93–99 (1988). ArticleCASPubMed Google Scholar
Tummuru, M. K., Cover, T. L. & Blaser, M. J. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immun.61, 1799–1809 (1993). ArticleCASPubMedPubMed Central Google Scholar
Covacci, A. et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl Acad. Sci. USA90, 5791–5795 (1993). ArticleCASPubMedPubMed Central Google Scholar
Tummuru, M. K., Cover, T. L. & Blaser, M. J. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect. Immun.62, 2609–2613 (1994). ArticleCASPubMedPubMed Central Google Scholar
Miehlke, S. et al. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int. J. Cancer87, 322–327 (2000). ArticleCASPubMed Google Scholar
Atherton, J. C. et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem.270, 17771–17777 (1995).The first study to show that specificvacAalleles affect the risk of developing clinical disease in individuals infected withH. pylori. ArticleCASPubMed Google Scholar
van Doorn, L. J. et al. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology116, 823–830 (1999). ArticleCASPubMed Google Scholar
Atherton, J. C., Peek, R. M. Jr, Tham, K. T., Cover, T. L. & Blaser, M. J. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology112, 92–99 (1997). ArticleCASPubMed Google Scholar
Ghiara, P. et al. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect. Immun.63, 4154–4160 (1995). ArticleCASPubMedPubMed Central Google Scholar
Ilver, D. et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science279, 373–377 (1998). ArticleCASPubMed Google Scholar
Guruge, J. L. et al. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc. Natl Acad. Sci. USA95, 3925–3930 (1998).One of the first articles to emphasize that interactions between specificH. pyloriand host determinants influence the development of premalignant lesions within inflamed gastric mucosa. ArticleCASPubMedPubMed Central Google Scholar
Mohammadi, M., Czinn, S., Redline, R. & Nedrud, J. _Helicobacter_-specific cell-mediated immune responses display a predominant TH1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol.156, 4729–4738 (1996). CASPubMed Google Scholar
Bamford, K. B. et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology114, 482–492 (1998). ArticleCASPubMed Google Scholar
Fox, J. G. et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces _Helicobacter_-induced gastric atrophy. Nature Med.6, 536–542 (2000). ArticleCASPubMed Google Scholar
Noach, L. A. et al. Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol.29, 425–429 (1994). ArticleCASPubMed Google Scholar
El-Omar, E. M. et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature404, 398–402 (2000).A remarkable paper showing that informative and functional host polymorphisms within theIL–1βgene augment the risk of gastric atrophy, hypochlorhydria and gastric cancer, but only in conjunction withH. pyloricolonization. ArticleCASPubMed Google Scholar
Takashima, M., Furuta, T., Hanai, H., Sugimura, H. & Kaneko, E. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut48, 765–773 (2001). ArticleCASPubMedPubMed Central Google Scholar
Beales, I. L. & Calam, J. Interleukin-1β and tumour necrosis factor-α inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut42, 227–234 (1998). ArticleCASPubMedPubMed Central Google Scholar
Crabtree, J. E., Shallcross, T. M., Heatley, R. V. & Wyatt, J. I. Mucosal tumour necrosis factor-α and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut32, 1473–1477 (1991). ArticleCASPubMedPubMed Central Google Scholar
Suganuma, M. et al. Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori. Cancer Res.61, 6356–6359 (2001). CASPubMed Google Scholar
El-Omar, E. M. et al. Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas. Gastroenterology120, A86 (2001). Article Google Scholar
Engstrand, L. et al. Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect. Immun.57, 827–832 (1989). ArticleCASPubMedPubMed Central Google Scholar
Azuma, T. et al. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer82, 1013–1018 (1998). ArticleCASPubMed Google Scholar
Guilford, P. et al. E-cadherin germline mutations in familial gastric cancer. Nature392, 402–405 (1998). ArticleCASPubMed Google Scholar
Shirin, H. et al. Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cells. Cancer Res.59, 2277–2281 (1999). CASPubMed Google Scholar
Ahmed, A. et al. Helicobacter pylori inhibits gastric cell cycle progression. Microbes Infect.2, 1159–1169 (2000). ArticleCASPubMed Google Scholar
Baik, S. C. et al. Increased oxidative DNA damage in _Helicobacter pylori_-infected human gastric mucosa. Cancer Res.56, 1279–1282 (1996). CASPubMed Google Scholar
Smoot, D. T. et al. Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury. Carcinogenesis21, 2091–2095 (2000). ArticleCASPubMed Google Scholar
Levi, S. et al. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet1, 1167–1168 (1989). ArticleCASPubMed Google Scholar
Hocker, M. et al. Gastrin and phorbol 12-myristate 13-acetate regulate the human histidine decarboxylase promoter through Raf-dependent activation of extracellular signal-regulated kinase-related signaling pathways in gastric cancer cells. J. Biol. Chem.272, 27015–27024 (1997). ArticleCASPubMed Google Scholar
Nagata, A. et al. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc. Natl Acad. Sci. USA93, 11825–11830 (1996). ArticleCASPubMedPubMed Central Google Scholar
Wang, T. C. et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology118, 36–47 (2000).ConcomitantHelicobacterinfection enhances and accelerates the development of gastric cancer in mice that overexpress gastrin, thereby delineating potential mechanisms through which transformation might occur within chronically inflamed gastric mucosa. ArticleCASPubMed Google Scholar
Williams, C. S., Smalley, W. & DuBois, R. N. Aspirin use and potential mechanisms for colorectal cancer prevention. J. Clin. Invest.100, 1325–1329 (1997). ArticleCASPubMedPubMed Central Google Scholar
Romano, M. et al. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J. Biol. Chem.273, 28560–28563 (1998). ArticleCASPubMed Google Scholar
Sawaoka, H. et al. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostaglandins Leukot. Essent. Fatty Acids59, 313–316 (1998). ArticleCASPubMed Google Scholar
Fu, S. et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology116, 1319–1329 (1999). ArticleCASPubMed Google Scholar
Sung, J. J. et al. Cyclooxygenase-2 expression in _Helicobacter pylori_-associated premalignant and malignant gastric lesions. Am. J. Pathol.157, 729–735 (2000). ArticleCASPubMedPubMed Central Google Scholar
Ristimaki, A., Honkanen, N., Jankala, H., Sipponen, P. & Harkonen, M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res.57, 1276–1280 (1997). CASPubMed Google Scholar
Farrow, D. C. et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol. Biomarkers Prev.7, 97–102 (1998). CASPubMed Google Scholar
Akre, K., Ekstrom, A. M., Signorello, L. B., Hansson, L. E. & Nyren, O. Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br. J. Cancer84, 965–968 (2001). ArticleCASPubMedPubMed Central Google Scholar
Pomorski, T., Meyer, T. F. & Naumann, M. _Helicobacter pylori_-induced prostaglandin E(2) synthesis involves activation of cytosolic phospholipase A(2) in epithelial cells. J. Biol. Chem.276, 804–810 (2001). ArticleCASPubMed Google Scholar
Nardone, G. et al. In vivo and in vitro studies of cytosolic phospholipase A(2) expression in Helicobacter pylori infection. Infect. Immun.69, 5857–5863 (2001). ArticleCASPubMedPubMed Central Google Scholar
Mannick, E. E. et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res.56, 3238–3243 (1996). CASPubMed Google Scholar
Correa, P. et al. Review article: antioxidant micronutrients and gastric cancer. Aliment. Pharmacol. Ther.12 (Suppl. 1), 73–82 (1998). ArticleCASPubMed Google Scholar
Sobala, G. M. et al. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut34, 1038–1041 (1993). ArticleCASPubMedPubMed Central Google Scholar
Wagner, S. et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology113, 1836–1847 (1997). ArticleCASPubMed Google Scholar
Fan, X. et al. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J. Exp. Med.187, 1659–1669 (1998). ArticleCASPubMedPubMed Central Google Scholar
Fan, X. et al. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J. Immunol.165, 1918–1924 (2000). ArticleCASPubMed Google Scholar
Jones, N. L., Day, A. S., Jennings, H. A. & Sherman, P. M. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect. Immun.67, 4237–4242 (1999). ArticleCASPubMedPubMed Central Google Scholar
Houghton, J., Korah, R. M., Condon, M. R. & Kim, K. H. Apoptosis in _Helicobacter pylori_-associated gastric and duodenal ulcer disease is mediated via the Fas antigen pathway. Dig. Dis. Sci.44, 465–478 (1999). ArticleCASPubMed Google Scholar
Sawai, N. et al. Role of γ-interferon in _Helicobacter pylori_-induced gastric inflammatory responses in a mouse model. Infect. Immun.67, 279–285 (1999). ArticleCASPubMedPubMed Central Google Scholar
Smythies, L. E. et al. _Helicobacter pylori_-induced mucosal inflammation is TH1 mediated and exacerbated in IL-4, but not IFN-γ, gene-deficient mice. J. Immunol.165, 1022–1029 (2000). ArticleCASPubMed Google Scholar
Houghton, J. M., Bloch, L. M., Goldstein, M., Von Hagen, S. & Korah, R. M. In vivo disruption of the fas pathway abrogates gastric growth alterations secondary to Helicobacter infection. J. Infect. Dis.182, 856–864 (2000). ArticleCASPubMed Google Scholar
Gupta, R. A. et al. Activation of peroxisome proliferator-activated receptor-γ suppresses nuclear factor-κB-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells. J. Biol. Chem.276, 31059–31066 (2001). ArticleCASPubMed Google Scholar
Su, C. G. et al. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J. Clin. Invest.104, 383–389 (1999). ArticleCASPubMedPubMed Central Google Scholar
Nakajima, A. et al. Endogenous PPAR-γ mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology120, 460–469 (2001). ArticleCASPubMed Google Scholar
Forman, B. M. et al. 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR-γ. Cell83, 803–812 (1995). ArticleCASPubMed Google Scholar
Tsujii, M. & DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell83, 493–501 (1995). ArticleCASPubMed Google Scholar
Moss, S. F., Calam, J., Agarwal, B., Wang, S. & Holt, P. R. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut38, 498–501 (1996). ArticleCASPubMedPubMed Central Google Scholar
Jones, N. L., Shannon, P. T., Cutz, E., Yeger, H. & Sherman, P. M. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am. J. Pathol.151, 1695–1703 (1997). CASPubMedPubMed Central Google Scholar
Kohda, K. et al. Role of apoptosis induced by Helicobacter pylori infection in the development of duodenal ulcer. Gut44, 456–462 (1999). ArticleCASPubMedPubMed Central Google Scholar
Peek, R. M. Jr et al. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J. Natl Cancer Inst.89, 863–868 (1997). ArticleCASPubMed Google Scholar
Rokkas, T. et al. Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis. Dig. Dis. Sci.44, 487–493 (1999). ArticleCASPubMed Google Scholar
Moss, S. F. et al. Increased gastric epithelial cell apoptosis associated with colonization with cagA+Helicobacter pylori strains. Cancer Res.61, 1406–1411 (2001). CASPubMed Google Scholar
Kirschner, D. E. & Blaser, M. J. The dynamics of Helicobacter pylori infection of the human stomach. J. Theor. Biol.176, 281–290 (1995). ArticleCASPubMed Google Scholar
Karita, M., Tummuru, M. K., Wirth, H. P. & Blaser, M. J. Effect of growth phase and acid shock on Helicobacter pylori cagA expression. Infect. Immun.64, 4501–4507 (1996). ArticleCASPubMedPubMed Central Google Scholar
Allan, E., Clayton, C. L., McLaren, A., Wallace, D. M. & Wren, B. W. Characterization of the low-pH responses of Helicobacter pylori using genomic DNA arrays. Microbiology147, 2285–2292 (2001). ArticleCASPubMed Google Scholar
Lagergren, J., Bergstrom, R., Lindgren, A. & Nyren, O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med.340, 825–831 (1999). ArticleCASPubMed Google Scholar
Devesa, S. S., Blot, W. J. & Fraumeni, J. F. Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer83, 2049–2053 (1998). ArticleCASPubMed Google Scholar
Kang, J. Y. et al. Low frequency of endoscopic esophagitis in Asian patients. J. Clin. Gastroenterol.16, 70–73 (1993). ArticleCASPubMed Google Scholar
Iftikhar, S. Y., James, P. D., Steele, R. J., Hardcastle, J. D. & Atkinson, M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut33, 1155–1158 (1992). ArticleCASPubMedPubMed Central Google Scholar
Labenz, J. et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology112, 1442–1447 (1997). ArticleCASPubMed Google Scholar
Werdmuller, B. F. & Loffeld, R. J. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig. Dis. Sci.42, 103–105 (1997). ArticleCASPubMed Google Scholar
Varanasi, R. V., Fantry, G. T. & Wilson, K. T. Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Helicobacter3, 188–194 (1998). ArticleCASPubMed Google Scholar
Weston, A. P. et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am. J. Gastroenterol.95, 387–394 (2000). ArticleCASPubMed Google Scholar
Haruma, K. et al. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter5, 24–29 (2000). ArticleCASPubMed Google Scholar
Loffeld, R. J. et al. Colonization with cagA+Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus. Digestion62, 95–99 (2000). ArticleCASPubMed Google Scholar
Koike, T. et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut49, 330–334 (2001). ArticleCASPubMedPubMed Central Google Scholar